Miracle Mile Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Hold
22,717
﹤0.01% 989
2026
Q1
$87.9K Buy
22,717
+1,500
+7% +$6.16K ﹤0.01% 879
2025
Q4
$88.7K Buy
21,217
+3,000
+16% +$11.6K ﹤0.01% 851
2025
Q3
$59.9K Hold
18,217
﹤0.01% 816
2025
Q2
$25.9K Buy
18,217
+5,067
+39% +$7.2K ﹤0.01% 716
2025
Q1
$19.6K Hold
13,150
﹤0.01% 642
2024
Q4
$14.7K Hold
13,150
﹤0.01% 631
2024
Q3
$12.5K Hold
13,150
﹤0.01% 526
2024
Q2
$20.8K Hold
13,150
﹤0.01% 499
2024
Q1
$19.1K Buy
+13,150
New +$18.9K ﹤0.01% 504

Other funds holding PGEN

Miracle Mile Advisors's PGEN Position: Q2 2026 in Review

Miracle Mile Advisors held its Precigen (PGEN) position steady in Q2 2026 at 22,717 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #989.

Miracle Mile Advisors first reported a position in PGEN in Q1 2024 and has held it in 10 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Miracle Mile Advisors held 22,717 shares of Precigen worth $129K as of Q2 2026.
  • Miracle Mile Advisors left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #989 holding.
  • Miracle Mile Advisors first reported a position in Precigen in Q1 2024 and has held it in 10 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.